Churning, Confusion And Disruption — The Dark Side Of Marketplace Coverage
The Affordable Care Act has increased the number of people with insurance, but shopping around for plans puts a burden on patients, especially this year.
Jay Hancock
Jay Hancock was a senior correspondent for ϳԹ News until he retired in Feburary 2022.
Showing 61 - 80 of 265
-
-
Hospitals Find Asthma Hot Spots More Profitable To Neglect Than Fix
Months of reporting and rich hospital data portray life in the worst asthma hot spot in one of the worst asthma cities: Baltimore. The medical system knows how to help. But there’s no money in it.
-
Enrollment 2018
Obamacare Shopping Is Trickier Than Ever. Here’s A Cheat Sheet.
This year, more than ever, it is important to know your options.
By Jay Hancock -
Do Pharma’s Claims On Drug Prices Pass The Smell Test? We Found 5 Stinkers.
Drug companies are in the midst of a glossy publicity campaign to stop attempts to control rising pharma costs. But the devil is in the details.
By Jay Hancock -
News Analysis
Everyone Says We Must Control Exorbitant Drug Prices. So, Why Don’t We?
Any momentum to address prescription drug costs has been lost amid rancorous debates over replacing Obamacare and stalled by roadblocks erected via lobbying and industry cash.
By Jay Hancock -
How Below-The-Radar Mergers Fuel Health Care Monopolies
Most acquisitions by hospitals of physician practices are too small to trigger antitrust attention, study says. But a buying spree of “onesies and twosies” doctor practices has driven competition down and prices up.
By Jay Hancock -
Taking A U-Turn On Benefits, Big Employers Vow To Continue Offering Health Insurance
Three years ago, only about a quarter of the nation’s large employers were very confident they would have a health plan in 10 years. That number has now risen to 65 percent.
By Jay Hancock -
Despite Insurers’ Tactical Win On ACA’s Cost-Sharing Payments, Uncertainty Lingers
Court allows state attorneys general to join a pending legal challenge to keep billions in subsidies flowing to consumers and insurers, despite the Trump administration’s resistance.
By Jay Hancock -
Follow The Money: Drugmakers Deploy Political Cash As Prices And Anger Mount
Embattled opioid seller Mallinckrodt is one of many pharmaceutical companies boosting political contributions and lobbying on Capitol Hill.
-
Repeal & Replace Watch
Analysis: Senate’s Latest Health Blueprint Cuts Costs At The Expense Of Chronically Ill
The Senate draft bill released Thursday to replace the Affordable Care Act risks creating a high-cost ghetto for those with preexisting conditions or long-term sickness, experts say.
By Jay Hancock -
Repeal & Replace Watch
Promises Made To Protect Preexisting Conditions Prove Hollow
Experts say the loopholes would allow states to bypass some protections for people with preexisting conditions.
By Jay Hancock and Rachel Bluth -
Former Pharma Reps’ New Mission: To School Docs On High Drug Costs
One insurer is turning the tables on drugmakers with what may be a new job category: a sales force for cost-effective medicine.
By Jay Hancock -
With Drug Costs In Crosshairs, Health Firms Gave Generously To Trump’s Inauguration
Led by Pfizer and Amgen, about 10 health care firms contributed to President Donald Trump’s inauguration, which earned them entry into private events with the president and vice president.
-
Repeal & Replace Watch
Death By 1,000 Cuts: How Republicans Can Still Alter Your Coverage
There are many ways beyond legislative repeal for the Trump administration and congressional Republicans to unravel the Affordable Care Act.
By Jay Hancock -
Repeal & Replace Watch
Late Move To Dump ‘Essential’ Benefits Could Strand Chronically Ill
Republicans seek lower cost and more choice for health insurance sold to individuals, but cutting coverage standards could leave fewer comprehensive plans, analysts say.
By Jay Hancock -
Repeal & Replace Watch
With ‘Trumpcare’ On Horizon, Voters Go Wobbly On Repeal
The prospect of repealing the Affordable Care Act – with no replacement ready – finds many having second thoughts.
By Jay Hancock -
Repeal & Replace Watch
‘Massive Confusion’ Abounds For Insurers As GOP Wavers On Obamacare Redo
Republicans’ delay in finding common ground to repeal and replace the health law raises risks that coverage could shrink and rates rise even more, the industry says.
By Jay Hancock -
Repeal & Replace Watch
Employers Fret Job-Based Coverage Vulnerable To Fallout From GOP Health Overhaul
Employer medical insurance still covers more people than any other kind. A Republican replacement for Obamacare could spread instability beyond the health law’s shaky marketplace plans.
By Jay Hancock -
Trump’s HHS Nominee Got A Sweetheart Deal From A Foreign Biotech Firm
Price and another influential GOP congressman got a discounted deal as an Australian firm seeking federal approval sought “sophisticated U.S. investors.”
By Jay Hancock and Rachel Bluth -
Signed Out Of Prison But Not Signed Up For Insurance, Inmates Fall Prey To Ills
States that expanded eligibility for Medicaid have failed to enroll large numbers of a significant group that stood to benefit: ex-inmates.
Sign Up For Our Newsletter
Stay informed by signing up for the Morning Briefing and other emails: